Prices are testing the October and November lows and also testing the rising 200-day moving average line.
Jim Cramer was bearish on TEVA.
A close below $105 for the drugmaker's shares would be bearish based on its charts.
Teladoc is not showing enough positive technical clues to warrant purchase.
I find a lot of Reuters' claims hard to believe. Even more difficult to believe is the selloff.
Shares of the healthcare company are showing unhealthy tendencies right now after a federal judge rules Obamacare unconstitutional.
Quotient Limited, Iovance Biotherapeutics and AVEO Pharmaceuticals are among the names seeing insider purchases.
Look for the big-cap stocks that only come in on tough days -- and take advantage of their weakness at the open.
Once the safest stocks in the book, the big-cap drug companies are now toxic.
The stock closed down on its first day of trading on the CSX. Here is a breakdown of the current landscape and some up-and-comers to keep an eye on.